meddevicedb.com FDA Device Reference

Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E)

K252052 Class II Traditional
Decision Date
2026-03-25
Sponsor / Applicant
Bausch and Lomb, Incorporated

Technical Specification

510(k) Submission ID K252052
Product Code HQC
Medical Specialty / Panel Ophthalmic
Regulation Citation 21 CFR 886.4670
Decision Date 2026-03-25
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E) received FDA 510(k) clearance under submission number K252052, sponsored by Bausch and Lomb, Incorporated. The device was reviewed via the Traditional premarket notification pathway and assigned to the Ophthalmic review panel. The statutory decision date of record is 2026-03-25.

Classification & Regulation

This clearance is catalogued under FDA product code HQC and 21 CFR 886.4670, within the Ophthalmic review panel as a Class II device.